US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Genprex, Inc.

3.70

+0.03380.92%

Volume:30.89K

Turnover:115.28K

Market Cap:3.04M

PE:-0.02

High:3.84

Open:3.73

Low:3.63

Close:3.67

52wk High:1,210.00

52wk Low:3.57

Shares:819.70K

Float Shares:818.70K

Volume Ratio:0.65

T/O Rate:3.77%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-173.0075

EPS(LYR):-382.7870

ROE:-203.86%

ROA:-94.46%

PB:0.21

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Genprex files $250M mixed securities shelf

Genprex Inc Files for Mixed Shelf of up to $250 Mln – SEC Filing

THOMSON REUTERS

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 Asco Annual Meeting

THOMSON REUTERS

Genprex collaborators present positive preclinical data of GPX-002 in diabetes

Genprex Q1 net loss widens 13% to $4.46 million year over year

Genprex Receives Patent Grant From the Israel Patent Office for the Combination of Reqorsa® Gene Therapy and Pd-1 Antibodies to Treat Cancer

THOMSON REUTERS

Genprex says Israel grants patent for Reqorsa plus PD-1 antibody cancer treatment combo

Genprex says diabetes gene therapy reverses hyperglycemia in preclinical Type 2 models

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy to Be Released at the 2026 Asco Annual Meeting

THOMSON REUTERS

Genprex signs MD Anderson research deal to study Reqorsa lung cancer response biomarkers

Genprex Signs Sponsored Research Agreement to Study Biomarkers That May Predict Patient Response to Reqorsa® Gene Therapy

THOMSON REUTERS

Genprex says Reqorsa gene therapy data support potential ALK+ NSCLC clinical trial

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 Aacr Annual Meeting

THOMSON REUTERS

Genprex announces annual shareholder meeting webcast

Genprex director Brent Longnecker disposes of USD 22 common shares

Genprex FY25 net loss narrows 23% to $16M

Genprex collaborators to present Reqorsa lung cancer preclinical data at AACR 2026

Genprex executives to attend BIO Europe Spring 2026

Genprex granted Japanese and EU patents for Reqorsa Gene Therapy

Genprex Wins Japanese and European Patent Grants for Reqorsa Gene Therapy Combinations With PD-1/PD-L1 Immunotherapies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/GNPX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNPX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNPX\",,,,,undefined,":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":3.7038,"timestamp":1788196200188,"preClose":3.67,"halted":0,"volume":30891,"delay":0,"changeRate":0.009209809264305252,"floatShares":818700,"shares":819700,"eps":-173.0075,"marketStatus":"Trading","change":0.0338,"latestTime":"08-31 13:17:39 EDT","open":3.73,"high":3.84,"low":3.6301,"amount":115283.9053107,"amplitude":0.057193,"askPrice":3.71,"askSize":200,"bidPrice":3.68,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-173.0075,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788206400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1522296000000,"exchange":"NASDAQ","adjPreClose":3.67,"preHourTrading":{"tag":"盘前","latestPrice":3.68,"preClose":3.67,"latestTime":"09:00 EDT","volume":2353,"amount":8585.5847519,"timestamp":1788181255381,"change":0.01,"changeRate":0.002725,"amplitude":0.043597},"postHourTrading":{"tag":"盘后","latestPrice":3.65,"preClose":3.67,"latestTime":"19:58 EDT","volume":2479,"amount":9065.3381,"timestamp":1787961520720,"change":-0.02,"changeRate":-0.00545,"amplitude":0.00545},"volumeRatio":0.647681,"impliedVol":3.1839,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNPX\",,,,,undefined,":{"symbol":"GNPX","floatShares":818700,"roa":"-94.46%","roe":"-203.86%","lyrEps":-382.787042,"volumeRatio":0.647681,"shares":819700,"dividePrice":0,"high":3.84,"amplitude":0.057193,"preClose":3.67,"low":3.6301,"week52Low":3.57,"pbRate":"0.21","week52High":1210,"institutionHeld":0,"latestPrice":3.7038,"committee":0.428571,"eps":-173.0075,"divideRate":0,"volume":30891,"delay":0,"ttmEps":-173.0075,"open":3.73,"prevYearClose":38.5,"prevWeekClose":3.67,"prevMonthClose":5.99,"prevQuarterClose":11.418,"fiveDayClose":4.02,"twentyDayClose":4.75,"sixtyDayClose":15.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNPX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"GNPX","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-9.4},{"market":"US","date":"2026-07-16","symbol":"GNPX","defaultRemindTime":1784208600000,"type":"split","dateTimestamp":1784174400000,"forFactor":22,"toFactor":1,"ratio":22},{"market":"US","date":"2026-05-13","symbol":"GNPX","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2026-03-30","symbol":"GNPX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-14","symbol":"GNPX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNPX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNPX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GNPX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GNPX","date":"2026-08-28","current":-0.022196,"percent":0.861928,"low":-8.741506,"twenty":-3.51064,"median":-0.486932,"eighty":-0.230872,"high":-0.045425,"avg":-1.695323,"sd":1.955728,"marketCap":2959149},"quantilePoints":[{"date":"2021-09-03","current":-7.895981,"twenty":-10.864666,"median":-7.298278,"eighty":-1.806855,"marketCap":145910520},{"date":"2021-09-10","current":-7.510184,"twenty":-10.831628,"median":-7.306975,"eighty":-1.822549,"marketCap":138781342},{"date":"2021-09-17","current":-7.330145,"twenty":-10.798701,"median":-7.306975,"eighty":-1.826473,"marketCap":135454392},{"date":"2021-09-24","current":-7.175826,"twenty":-10.767587,"median":-7.298278,"eighty":-1.833664,"marketCap":132602721},{"date":"2021-10-01","current":-6.944348,"twenty":-10.758048,"median":-7.28958,"eighty":-1.835462,"marketCap":128325213},{"date":"2021-10-08","current":-6.352792,"twenty":-10.72838,"median":-7.280446,"eighty":-1.835462,"marketCap":117393806},{"date":"2021-10-15","current":-6.198473,"twenty":-10.698418,"median":-7.255341,"eighty":-1.848012,"marketCap":114542135},{"date":"2021-10-22","current":-5.889836,"twenty":-10.66998,"median":-7.246475,"eighty":-1.885526,"marketCap":108838792},{"date":"2021-10-29","current":-5.992715,"twenty":-10.664292,"median":-7.21558,"eighty":-1.897394,"marketCap":110739906},{"date":"2021-11-05","current":-5.581198,"twenty":-10.571434,"median":-7.175826,"eighty":-1.899493,"marketCap":103135449},{"date":"2021-11-12","current":-5.324,"twenty":-10.54822,"median":-7.149395,"eighty":-1.911083,"marketCap":98382663},{"date":"2021-11-19","current":-4.345777,"twenty":-10.506027,"median":-7.110869,"eighty":-1.9139,"marketCap":83186911},{"date":"2021-11-26","current":-3.946166,"twenty":-10.495479,"median":-7.071943,"eighty":-1.923313,"marketCap":75537540},{"date":"2021-12-03","current":-3.321772,"twenty":-10.494401,"median":-7.032575,"eighty":-1.935366,"marketCap":63585398},{"date":"2021-12-10","current":-3.671432,"twenty":-10.4772,"median":-6.999197,"eighty":-1.959512,"marketCap":70278597},{"date":"2021-12-17","current":-3.446651,"twenty":-10.466212,"median":-6.995787,"eighty":-1.993335,"marketCap":65975826},{"date":"2021-12-23","current":-3.596505,"twenty":-10.456822,"median":-6.982927,"eighty":-2.006865,"marketCap":68844340},{"date":"2021-12-31","current":-3.271821,"twenty":-10.432189,"median":-6.940675,"eighty":-2.007267,"marketCap":62629226},{"date":"2022-01-07","current":-5.544612,"twenty":-10.415963,"median":-6.937002,"eighty":-2.00787,"marketCap":106135025},{"date":"2022-01-14","current":-5.644515,"twenty":-10.412554,"median":-6.869229,"eighty":-2.011978,"marketCap":108047368},{"date":"2022-01-21","current":-4.545583,"twenty":-10.405766,"median":-6.830954,"eighty":-2.019255,"marketCap":87011597},{"date":"2022-01-28","current":-4.570559,"twenty":-10.394679,"median":-6.815749,"eighty":-2.026852,"marketCap":87489683},{"date":"2022-02-04","current":-5.494661,"twenty":-10.391334,"median":-6.786437,"eighty":-2.04254,"marketCap":105178854},{"date":"2022-02-11","current":-5.61954,"twenty":-10.384722,"median":-6.764309,"eighty":-2.057219,"marketCap":107569282},{"date":"2022-02-18","current":-5.519637,"twenty":-10.358352,"median":-6.660476,"eighty":-2.066743,"marketCap":105656939},{"date":"2022-02-25","current":-5.569588,"twenty":-10.337255,"median":-6.635549,"eighty":-2.070777,"marketCap":106613111},{"date":"2022-03-04","current":-5.344806,"twenty":-10.337255,"median":-6.597859,"eighty":-2.076582,"marketCap":102310339},{"date":"2022-03-11","current":-5.269879,"twenty":-10.298955,"median":-6.585551,"eighty":-2.109687,"marketCap":100876082},{"date":"2022-03-18","current":-6.069103,"twenty":-10.258144,"median":-6.558551,"eighty":-2.11784,"marketCap":116174825},{"date":"2022-03-25","current":-5.919248,"twenty":-10.231773,"median":-6.532831,"eighty":-2.134802,"marketCap":113306310},{"date":"2022-04-01","current":-5.448755,"twenty":-10.226597,"median":-6.495202,"eighty":-2.14736,"marketCap":106771748},{"date":"2022-04-08","current":-5.033379,"twenty":-10.222017,"median":-6.428566,"eighty":-2.159223,"marketCap":98632198},{"date":"2022-04-14","current":-4.862342,"twenty":-10.208726,"median":-6.373813,"eighty":-2.163768,"marketCap":95280618},{"date":"2022-04-22","current":-4.275929,"twenty":-10.203063,"median":-6.301353,"eighty":-2.177454,"marketCap":83789489},{"date":"2022-04-29","current":-3.909829,"twenty":-10.193702,"median":-6.197764,"eighty":-2.180591,"marketCap":76615532},{"date":"2022-05-06","current":-3.738774,"twenty":-10.181527,"median":-6.135392,"eighty":-2.190173,"marketCap":73263603},{"date":"2022-05-13","current":-3.866792,"twenty":-10.178493,"median":-6.056629,"eighty":-2.195537,"marketCap":72805493},{"date":"2022-05-20","current":-3.841353,"twenty":-10.144926,"median":-6.018435,"eighty":-2.196279,"marketCap":72326510},{"date":"2022-05-27","current":-3.815913,"twenty":-10.13141,"median":-5.968469,"eighty":-2.196763,"marketCap":71847526},{"date":"2022-06-03","current":-3.790474,"twenty":-10.127823,"median":-5.931736,"eighty":-2.196884,"marketCap":71368542},{"date":"2022-06-10","current":-3.612398,"twenty":-10.114116,"median":-5.915556,"eighty":-2.204416,"marketCap":68015658},{"date":"2022-06-17","current":-3.332564,"twenty":-10.102352,"median":-5.892055,"eighty":-2.209864,"marketCap":62746839},{"date":"2022-06-24","current":-3.561519,"twenty":-10.092603,"median":-5.866707,"eighty":-2.210876,"marketCap":67057691},{"date":"2022-07-01","current":-3.51064,"twenty":-10.078396,"median":-5.844321,"eighty":-2.213751,"marketCap":66099724},{"date":"2022-07-08","current":-3.637837,"twenty":-10.069671,"median":-5.769394,"eighty":-2.218672,"marketCap":68494641},{"date":"2022-07-15","current":-3.663277,"twenty":-10.049506,"median":-5.706955,"eighty":-2.227654,"marketCap":68973625},{"date":"2022-07-22","current":-3.586959,"twenty":-10.029049,"median":-5.694467,"eighty":-2.227654,"marketCap":67536674},{"date":"2022-07-29","current":-3.53608,"twenty":-10.021472,"median":-5.676784,"eighty":-2.227905,"marketCap":66578707},{"date":"2022-08-05","current":-3.637837,"twenty":-10.020809,"median":-5.669491,"eighty":-2.230011,"marketCap":68494641},{"date":"2022-08-12","current":-4.247333,"twenty":-10.017548,"median":-5.651436,"eighty":-2.234588,"marketCap":84995938},{"date":"2022-08-19","current":-4.799246,"twenty":-10.000269,"median":-5.644515,"eighty":-2.235264,"marketCap":96040608},{"date":"2022-08-26","current":-4.487295,"twenty":-9.980272,"median":-5.639221,"eighty":-2.235844,"marketCap":89797968},{"date":"2022-09-02","current":-3.887389,"twenty":-9.968068,"median":-5.61954,"eighty":-2.238194,"marketCap":77792892},{"date":"2022-09-09","current":-4.223337,"twenty":-9.968068,"median":-5.581198,"eighty":-2.23831,"marketCap":84515735},{"date":"2022-09-16","current":-3.767408,"twenty":-9.91647,"median":-5.544612,"eighty":-2.247098,"marketCap":75391877},{"date":"2022-09-23","current":-3.383468,"twenty":-9.888956,"median":-5.522056,"eighty":-2.249454,"marketCap":67708628},{"date":"2022-09-30","current":-3.383468,"twenty":-9.862585,"median":-5.519637,"eighty":-2.25903,"marketCap":67708628},{"date":"2022-10-07","current":-3.287484,"twenty":-9.861864,"median":-5.494661,"eighty":-2.25903,"marketCap":65787816},{"date":"2022-10-14","current":-3.191499,"twenty":-9.836215,"median":-5.47363,"eighty":-2.259652,"marketCap":63867004},{"date":"2022-10-21","current":-3.071518,"twenty":-9.836215,"median":-5.444709,"eighty":-2.260379,"marketCap":61465989},{"date":"2022-10-28","current":-3.383468,"twenty":-9.816568,"median":-5.347983,"eighty":-2.260379,"marketCap":67708628},{"date":"2022-11-04","current":-3.167502,"twenty":-9.816568,"median":-5.344806,"eighty":-2.260379,"marketCap":63386801},{"date":"2022-11-11","current":-3.335476,"twenty":-9.816568,"median":-5.321915,"eighty":-2.260379,"marketCap":66748222},{"date":"2022-11-18","current":-2.713233,"twenty":-9.805788,"median":-5.269879,"eighty":-2.263422,"marketCap":61472414},{"date":"2022-11-25","current":-2.734431,"twenty":-9.793914,"median":-5.195401,"eighty":-2.266011,"marketCap":61952667},{"date":"2022-12-02","current":-2.776825,"twenty":-9.788025,"median":-5.174979,"eighty":-2.271681,"marketCap":62913174},{"date":"2022-12-09","current":-2.681438,"twenty":-9.784238,"median":-5.14919,"eighty":-2.273037,"marketCap":60752034},{"date":"2022-12-16","current":-2.501262,"twenty":-9.783474,"median":-5.120025,"eighty":-2.274386,"marketCap":56669882},{"date":"2022-12-23","current":-2.119714,"twenty":-9.780257,"median":-5.120025,"eighty":-2.266011,"marketCap":48025324},{"date":"2022-12-30","current":-3.073585,"twenty":-9.779453,"median":-5.093623,"eighty":-2.265364,"marketCap":69636719},{"date":"2023-01-06","current":-3.03119,"twenty":-9.770513,"median":-5.045098,"eighty":-2.26917,"marketCap":68676213},{"date":"2023-01-13","current":-3.03119,"twenty":-9.746555,"median":-5.039238,"eighty":-2.272987,"marketCap":68676213},{"date":"2023-01-20","current":-2.771102,"twenty":-9.727712,"median":-5.005179,"eighty":-2.273393,"marketCap":62783506},{"date":"2023-01-27","current":-2.840416,"twenty":-9.715331,"median":-4.970171,"eighty":-2.274717,"marketCap":64353934},{"date":"2023-02-03","current":-3.62471,"twenty":-9.69636,"median":-4.953595,"eighty":-2.274717,"marketCap":82123304},{"date":"2023-02-10","current":-3.264359,"twenty":-9.624923,"median":-4.920219,"eighty":-2.274717,"marketCap":73958998},{"date":"2023-02-17","current":-3.62471,"twenty":-9.618667,"median":-4.866305,"eighty":-2.276872,"marketCap":82123304},{"date":"2023-02-24","current":-2.882811,"twenty":-9.59888,"median":-4.853817,"eighty":-2.285494,"marketCap":65314440},{"date":"2023-03-03","current":-2.615162,"twenty":-9.582151,"median":-4.815789,"eighty":-2.297312,"marketCap":59250448},{"date":"2023-03-10","current":-2.065748,"twenty":-9.55969,"median":-4.781926,"eighty":-2.297312,"marketCap":46802657},{"date":"2023-03-17","current":-1.777392,"twenty":-9.551256,"median":-4.751254,"eighty":-2.274717,"marketCap":40269515},{"date":"2023-03-24","current":-2.064601,"twenty":-9.546139,"median":-4.703273,"eighty":-2.266658,"marketCap":46776670},{"date":"2023-03-31","current":-2.087312,"twenty":-9.544825,"median":-4.625539,"eighty":-2.260379,"marketCap":47291213},{"date":"2023-04-06","current":-1.835201,"twenty":-9.477575,"median":-4.588917,"eighty":-2.257115,"marketCap":41579262},{"date":"2023-04-14","current":-1.854292,"twenty":-9.391461,"median":-4.500911,"eighty":-2.235264,"marketCap":44022044},{"date":"2023-04-21","current":-2.408171,"twenty":-9.372825,"median":-4.45103,"eighty":-2.227654,"marketCap":57171485},{"date":"2023-04-28","current":-1.798466,"twenty":-9.339055,"median":-4.343318,"eighty":-2.213847,"marketCap":42696705},{"date":"2023-05-05","current":-1.72792,"twenty":-9.292981,"median":-4.275929,"eighty":-2.196642,"marketCap":41021888},{"date":"2023-05-12","current":-1.780029,"twenty":-9.240822,"median":-4.204554,"eighty":-2.175296,"marketCap":42258990},{"date":"2023-05-19","current":-1.663988,"twenty":-9.160106,"median":-4.127352,"eighty":-2.151109,"marketCap":39504099},{"date":"2023-05-26","current":-1.59886,"twenty":-9.027812,"median":-4.080458,"eighty":-2.119714,"marketCap":44182216},{"date":"2023-06-02","current":-1.756865,"twenty":-8.976535,"median":-4.071044,"eighty":-2.094469,"marketCap":48548458},{"date":"2023-06-09","current":-1.698553,"twenty":-8.916846,"median":-4.012381,"eighty":-2.071201,"marketCap":46937107},{"date":"2023-06-16","current":-1.599236,"twenty":-8.860505,"median":-3.982287,"eighty":-2.060797,"marketCap":44192612},{"date":"2023-06-23","current":-1.45026,"twenty":-8.813799,"median":-3.963765,"eighty":-2.01972,"marketCap":40075869},{"date":"2023-06-30","current":-1.542429,"twenty":-8.763841,"median":-3.933678,"eighty":-2.00787,"marketCap":42622843},{"date":"2023-07-07","current":-1.604315,"twenty":-8.740526,"median":-3.886391,"eighty":-1.960912,"marketCap":44332955},{"date":"2023-07-14","current":-1.561804,"twenty":-8.639414,"median":-3.843275,"eighty":-1.927191,"marketCap":43158228},{"date":"2023-07-21","current":-1.627075,"twenty":-8.609679,"median":-3.815913,"eighty":-1.899813,"marketCap":44961902},{"date":"2023-07-28","current":-1.512142,"twenty":-8.570756,"median":-3.790474,"eighty":-1.859059,"marketCap":41785898},{"date":"2023-08-04","current":-1.571587,"twenty":-8.520384,"median":-3.771335,"eighty":-1.835462,"marketCap":43428579},{"date":"2023-08-11","current":-1.38046,"twenty":-8.490003,"median":-3.751893,"eighty":-1.822679,"marketCap":38147046},{"date":"2023-08-18","current":-1.177723,"twenty":-8.477195,"median":-3.739595,"eighty":-1.805771,"marketCap":32544700},{"date":"2023-08-25","current":-0.911773,"twenty":-8.477195,"median":-3.714156,"eighty":-1.796113,"marketCap":27215639},{"date":"2023-09-01","current":-1.034378,"twenty":-8.477195,"median":-3.688716,"eighty":-1.788747,"marketCap":30875284},{"date":"2023-09-08","current":-1.00711,"twenty":-8.47978,"median":-3.671432,"eighty":-1.784421,"marketCap":30061369},{"date":"2023-09-15","current":-1.025223,"twenty":-8.482366,"median":-3.663277,"eighty":-1.779269,"marketCap":30601999},{"date":"2023-09-22","current":-0.855447,"twenty":-8.482366,"median":-3.637837,"eighty":-1.759498,"marketCap":25534341},{"date":"2023-09-29","current":-0.756527,"twenty":-8.482366,"median":-3.612398,"eighty":-1.749089,"marketCap":22581673},{"date":"2023-10-06","current":-0.736425,"twenty":-8.482366,"median":-3.599435,"eighty":-1.731376,"marketCap":21981634},{"date":"2023-10-13","current":-0.655816,"twenty":-8.482366,"median":-3.586959,"eighty":-1.702418,"marketCap":19575536},{"date":"2023-10-20","current":-0.615014,"twenty":-8.484951,"median":-3.591732,"eighty":-1.691713,"marketCap":18357634},{"date":"2023-10-27","current":-0.423324,"twenty":-8.49247,"median":-3.599435,"eighty":-1.68314,"marketCap":12635843},{"date":"2023-11-03","current":-0.498988,"twenty":-8.49247,"median":-3.599435,"eighty":-1.649005,"marketCap":14894366},{"date":"2023-11-10","current":-0.44005,"twenty":-8.49247,"median":-3.599435,"eighty":-1.632997,"marketCap":13135095},{"date":"2023-11-17","current":-0.449421,"twenty":-8.49247,"median":-3.599435,"eighty":-1.621882,"marketCap":14163318},{"date":"2023-11-24","current":-0.529069,"twenty":-8.49247,"median":-3.599435,"eighty":-1.614381,"marketCap":16641750},{"date":"2023-12-01","current":-0.457266,"twenty":-8.49247,"median":-3.599435,"eighty":-1.595199,"marketCap":14383226},{"date":"2023-12-08","current":-0.434592,"twenty":-8.490003,"median":-3.59797,"eighty":-1.577064,"marketCap":13670009},{"date":"2023-12-15","current":-0.421365,"twenty":-8.490003,"median":-3.59797,"eighty":-1.555884,"marketCap":13253965},{"date":"2023-12-22","current":-0.394912,"twenty":-8.490003,"median":-3.59797,"eighty":-1.542198,"marketCap":12421877},{"date":"2023-12-29","current":-0.434592,"twenty":-8.49247,"median":-3.599435,"eighty":-1.511616,"marketCap":13670009},{"date":"2024-01-05","current":-0.434592,"twenty":-8.494936,"median":-3.605917,"eighty":-1.486894,"marketCap":13670009},{"date":"2024-01-12","current":-0.409083,"twenty":-8.494936,"median":-3.605917,"eighty":-1.471591,"marketCap":12867638},{"date":"2024-01-19","current":-0.390377,"twenty":-8.497403,"median":-3.612398,"eighty":-1.402651,"marketCap":12279234},{"date":"2024-01-26","current":-0.430435,"twenty":-8.494936,"median":-3.605917,"eighty":-1.372291,"marketCap":13539252},{"date":"2024-02-02","current":-0.346729,"twenty":-8.494936,"median":-3.605917,"eighty":-1.339755,"marketCap":10906285},{"date":"2024-02-09","current":-0.208321,"twenty":-8.494936,"median":-3.605917,"eighty":-1.314773,"marketCap":6552686},{"date":"2024-02-16","current":-0.206904,"twenty":-8.494936,"median":-3.605917,"eighty":-1.284337,"marketCap":6508110},{"date":"2024-02-23","current":-0.207848,"twenty":-8.494936,"median":-3.605917,"eighty":-1.265892,"marketCap":6537828},{"date":"2024-03-01","current":-0.203124,"twenty":-8.49247,"median":-3.599435,"eighty":-1.254668,"marketCap":6389241},{"date":"2024-03-08","current":-0.200763,"twenty":-8.49247,"median":-3.599435,"eighty":-1.240197,"marketCap":6314947},{"date":"2024-03-15","current":-0.196511,"twenty":-8.49247,"median":-3.599435,"eighty":-1.229176,"marketCap":6181219},{"date":"2024-03-22","current":-0.142659,"twenty":-8.49247,"median":-3.599435,"eighty":-1.224346,"marketCap":4487327},{"date":"2024-03-28","current":-0.128016,"twenty":-8.49247,"median":-3.599435,"eighty":-1.215365,"marketCap":4026707},{"date":"2024-04-05","current":-0.185098,"twenty":-8.494936,"median":-3.605917,"eighty":-1.202437,"marketCap":5712218},{"date":"2024-04-12","current":-0.172098,"twenty":-8.494936,"median":-3.605917,"eighty":-1.194249,"marketCap":5311025},{"date":"2024-04-19","current":-0.137394,"twenty":-8.494936,"median":-3.605917,"eighty":-1.157359,"marketCap":4240032},{"date":"2024-04-26","current":-0.13124,"twenty":-8.49247,"median":-3.599435,"eighty":-1.104089,"marketCap":4050134},{"date":"2024-05-03","current":-0.160494,"twenty":-8.49247,"median":-3.599435,"eighty":-1.06657,"marketCap":4952927},{"date":"2024-05-10","current":-0.165255,"twenty":-8.49247,"median":-3.599435,"eighty":-1.034736,"marketCap":5099836},{"date":"2024-05-17","current":-0.183839,"twenty":-8.49247,"median":-3.599435,"eighty":-1.01129,"marketCap":5078849},{"date":"2024-05-24","current":-0.167634,"twenty":-8.49247,"median":-3.599435,"eighty":-0.977772,"marketCap":4631154},{"date":"2024-05-31","current":-0.183563,"twenty":-8.49247,"median":-3.599435,"eighty":-0.959893,"marketCap":5071218},{"date":"2024-06-07","current":-0.207457,"twenty":-8.49247,"median":-3.599435,"eighty":-0.925746,"marketCap":5731315},{"date":"2024-06-14","current":-0.183563,"twenty":-8.494936,"median":-3.605917,"eighty":-0.896806,"marketCap":5071218},{"date":"2024-06-21","current":-0.155498,"twenty":-8.497403,"median":-3.612398,"eighty":-0.856995,"marketCap":4295867},{"date":"2024-06-28","current":-0.14943,"twenty":-8.500834,"median":-3.612398,"eighty":-0.789805,"marketCap":4128223},{"date":"2024-07-05","current":-0.144878,"twenty":-8.500834,"median":-3.612398,"eighty":-0.75175,"marketCap":4002490},{"date":"2024-07-12","current":-0.139569,"twenty":-8.500834,"median":-3.612398,"eighty":-0.725518,"marketCap":3855802},{"date":"2024-07-15","current":-0.145637,"twenty":-8.500834,"median":-3.612398,"eighty":-0.722479,"marketCap":4023446},{"date":"2024-08-02","current":-0.127432,"twenty":-8.515816,"median":-3.637837,"eighty":-0.700599,"marketCap":3520515},{"date":"2024-08-09","current":-0.107711,"twenty":-8.515816,"median":-3.637837,"eighty":-0.696618,"marketCap":2975673},{"date":"2024-08-16","current":-0.06455,"twenty":-8.515816,"median":-3.637837,"eighty":-0.6831,"marketCap":1687473},{"date":"2024-08-23","current":-0.096384,"twenty":-8.515816,"median":-3.637837,"eighty":-0.664031,"marketCap":2519695},{"date":"2024-08-30","current":-0.092434,"twenty":-8.515816,"median":-3.637837,"eighty":-0.649115,"marketCap":2416417},{"date":"2024-09-06","current":-0.068688,"twenty":-8.515816,"median":-3.637837,"eighty":-0.635185,"marketCap":1795669},{"date":"2024-09-13","current":-0.05919,"twenty":-8.515816,"median":-3.637837,"eighty":-0.628095,"marketCap":1547370},{"date":"2024-09-20","current":-0.053684,"twenty":-8.515816,"median":-3.637837,"eighty":-0.596902,"marketCap":1403429},{"date":"2024-09-27","current":-0.048109,"twenty":-8.515816,"median":-3.637837,"eighty":-0.58349,"marketCap":1257688},{"date":"2024-10-04","current":-0.045425,"twenty":-8.515816,"median":-3.637837,"eighty":-0.530036,"marketCap":1187517},{"date":"2024-10-11","current":-0.046774,"twenty":-8.515816,"median":-3.637837,"eighty":-0.525687,"marketCap":1222782},{"date":"2024-10-18","current":-0.046788,"twenty":-8.515816,"median":-3.637837,"eighty":-0.498907,"marketCap":1223142},{"date":"2024-10-25","current":-0.294576,"twenty":-8.515816,"median":-3.637837,"eighty":-0.489223,"marketCap":7700869},{"date":"2024-10-31","current":-0.278058,"twenty":-8.515816,"median":-3.637837,"eighty":-0.475673,"marketCap":7269044},{"date":"2024-11-08","current":-0.232632,"twenty":-8.51619,"median":-3.637837,"eighty":-0.467657,"marketCap":6081527},{"date":"2024-11-15","current":-0.259868,"twenty":-8.51619,"median":-3.637837,"eighty":-0.459349,"marketCap":5901600},{"date":"2024-11-22","current":-0.18064,"twenty":-8.51619,"median":-3.637837,"eighty":-0.455934,"marketCap":4102332},{"date":"2024-11-29","current":-0.408358,"twenty":-8.51619,"median":-3.637837,"eighty":-0.454848,"marketCap":9273794},{"date":"2024-12-06","current":-0.404612,"twenty":-8.51619,"median":-3.637837,"eighty":-0.447819,"marketCap":9188713},{"date":"2024-12-13","current":-0.397119,"twenty":-8.51619,"median":-3.637837,"eighty":-0.445625,"marketCap":9018552},{"date":"2024-12-20","current":-0.337176,"twenty":-8.51619,"median":-3.637837,"eighty":-0.443656,"marketCap":7657261},{"date":"2024-12-27","current":-0.33343,"twenty":-8.51619,"median":-3.637837,"eighty":-0.443656,"marketCap":7572180},{"date":"2025-01-03","current":-0.337514,"twenty":-8.51619,"median":-3.637837,"eighty":-0.44005,"marketCap":7664918},{"date":"2025-01-10","current":-0.288885,"twenty":-8.516564,"median":-3.637837,"eighty":-0.434592,"marketCap":6560571},{"date":"2025-01-17","current":-0.262248,"twenty":-8.516564,"median":-3.637837,"eighty":-0.430359,"marketCap":5955647},{"date":"2025-01-24","current":-0.264122,"twenty":-8.516564,"median":-3.637837,"eighty":-0.419173,"marketCap":5998187},{"date":"2025-01-31","current":-0.228531,"twenty":-8.516564,"median":-3.62471,"eighty":-0.411879,"marketCap":5189921},{"date":"2025-02-07","current":-0.18732,"twenty":-8.516564,"median":-3.621481,"eighty":-0.408358,"marketCap":4254034},{"date":"2025-02-14","current":-0.176456,"twenty":-8.516564,"median":-3.612398,"eighty":-0.404058,"marketCap":4007300},{"date":"2025-02-21","current":-0.14817,"twenty":-8.49247,"median":-3.596505,"eighty":-0.399258,"marketCap":3364940},{"date":"2025-02-28","current":-0.14049,"twenty":-8.420685,"median":-3.561119,"eighty":-0.394912,"marketCap":3190525},{"date":"2025-03-07","current":-0.125505,"twenty":-8.382425,"median":-3.53608,"eighty":-0.389926,"marketCap":2850202},{"date":"2025-03-14","current":-0.134908,"twenty":-8.382425,"median":-3.51064,"eighty":-0.364966,"marketCap":3063755},{"date":"2025-03-21","current":-0.14064,"twenty":-8.370864,"median":-3.479453,"eighty":-0.343245,"marketCap":3193928},{"date":"2025-03-28","current":-0.128127,"twenty":-8.370864,"median":-3.453207,"eighty":-0.330126,"marketCap":2909759},{"date":"2025-04-04","current":-0.171687,"twenty":-8.370864,"median":-3.421602,"eighty":-0.317305,"marketCap":3672082},{"date":"2025-04-11","current":-0.299253,"twenty":-8.367064,"median":-3.383468,"eighty":-0.297933,"marketCap":6400504},{"date":"2025-04-17","current":-0.288525,"twenty":-8.367064,"median":-3.371724,"eighty":-0.294188,"marketCap":6171052},{"date":"2025-04-25","current":-0.300947,"twenty":-8.370864,"median":-3.353576,"eighty":-0.288026,"marketCap":6436733},{"date":"2025-05-02","current":-0.310884,"twenty":-8.370864,"median":-3.332564,"eighty":-0.288026,"marketCap":6649279},{"date":"2025-05-09","current":-0.323984,"twenty":-8.291247,"median":-3.292403,"eighty":-0.288026,"marketCap":6929452},{"date":"2025-05-16","current":-0.295057,"twenty":-8.281861,"median":-3.278689,"eighty":-0.285135,"marketCap":5719394},{"date":"2025-05-23","current":-0.3287,"twenty":-8.281861,"median":-3.263487,"eighty":-0.285135,"marketCap":6371521},{"date":"2025-05-30","current":-0.414924,"twenty":-8.281861,"median":-3.246845,"eighty":-0.285135,"marketCap":8042898},{"date":"2025-06-06","current":-0.339914,"twenty":-8.281861,"median":-3.196134,"eighty":-0.285135,"marketCap":6588896},{"date":"2025-06-13","current":-0.390128,"twenty":-8.281861,"median":-3.167502,"eighty":-0.285135,"marketCap":7562256},{"date":"2025-06-20","current":-0.45194,"twenty":-8.280352,"median":-3.11951,"eighty":-0.284282,"marketCap":8760414},{"date":"2025-06-27","current":-0.350179,"twenty":-8.208524,"median":-3.095514,"eighty":-0.284282,"marketCap":6787870},{"date":"2025-07-03","current":-0.389537,"twenty":-8.161542,"median":-3.071518,"eighty":-0.284282,"marketCap":7550781},{"date":"2025-07-11","current":-0.435329,"twenty":-8.107477,"median":-3.022063,"eighty":-0.284282,"marketCap":8438425},{"date":"2025-07-18","current":-0.424255,"twenty":-8.0232,"median":-2.936322,"eighty":-0.284282,"marketCap":8223766},{"date":"2025-07-25","current":-0.488181,"twenty":-7.893378,"median":-2.861613,"eighty":-0.284282,"marketCap":9462911},{"date":"2025-08-01","current":-0.394991,"twenty":-7.832142,"median":-2.819219,"eighty":-0.284282,"marketCap":7656506},{"date":"2025-08-08","current":-0.378576,"twenty":-7.672084,"median":-2.776825,"eighty":-0.284282,"marketCap":7338313},{"date":"2025-08-15","current":-0.369342,"twenty":-7.547318,"median":-2.755628,"eighty":-0.284282,"marketCap":7159330},{"date":"2025-08-22","current":-0.274014,"twenty":-7.45155,"median":-2.692036,"eighty":-0.28207,"marketCap":4812523},{"date":"2025-08-29","current":-0.332894,"twenty":-7.38144,"median":-2.653034,"eighty":-0.28207,"marketCap":5846647},{"date":"2025-09-05","current":-0.296689,"twenty":-7.330145,"median":-2.607248,"eighty":-0.28173,"marketCap":5210778},{"date":"2025-09-12","current":-0.492577,"twenty":-7.275425,"median":-2.501262,"eighty":-0.28207,"marketCap":8651163},{"date":"2025-09-19","current":-0.597296,"twenty":-7.196402,"median":-2.423469,"eighty":-0.28207,"marketCap":10490355},{"date":"2025-09-26","current":-0.452553,"twenty":-7.062659,"median":-2.215101,"eighty":-0.28207,"marketCap":7948214},{"date":"2025-10-03","current":-0.488586,"twenty":-6.979987,"median":-2.133421,"eighty":-0.28207,"marketCap":8581067},{"date":"2025-10-10","current":-0.565049,"twenty":-6.810605,"median":-2.087312,"eighty":-0.28207,"marketCap":9924004},{"date":"2025-10-17","current":-1.161613,"twenty":-6.627287,"median":-2.064601,"eighty":-0.28207,"marketCap":20401488},{"date":"2025-10-24","current":-0.447544,"twenty":-6.347648,"median":-1.956252,"eighty":-0.28207,"marketCap":7860250},{"date":"2025-10-31","current":-0.358543,"twenty":-6.064113,"median":-1.897369,"eighty":-0.28207,"marketCap":6297124},{"date":"2025-11-07","current":-0.268193,"twenty":-5.983017,"median":-1.82408,"eighty":-0.278282,"marketCap":4710288},{"date":"2025-11-14","current":-0.294195,"twenty":-5.911299,"median":-1.805771,"eighty":-0.278282,"marketCap":5166964},{"date":"2025-11-21","current":-0.302506,"twenty":-5.864116,"median":-1.790585,"eighty":-0.278058,"marketCap":5156617},{"date":"2025-11-28","current":-0.28336,"twenty":-5.789375,"median":-1.784408,"eighty":-0.277901,"marketCap":4830249},{"date":"2025-12-05","current":-0.446176,"twenty":-5.694467,"median":-1.766235,"eighty":-0.27676,"marketCap":7605659},{"date":"2025-12-12","current":-0.431525,"twenty":-5.669491,"median":-1.753755,"eighty":-0.27676,"marketCap":7355921},{"date":"2025-12-19","current":-0.295196,"twenty":-5.644515,"median":-1.739748,"eighty":-0.27676,"marketCap":5031999},{"date":"2025-12-26","current":-0.253025,"twenty":-5.617016,"median":-1.698553,"eighty":-0.273449,"marketCap":4313142},{"date":"2026-01-02","current":-0.238061,"twenty":-5.544612,"median":-1.689166,"eighty":-0.270337,"marketCap":4058064},{"date":"2026-01-09","current":-0.27207,"twenty":-5.519637,"median":-1.63648,"eighty":-0.268073,"marketCap":4637788},{"date":"2026-01-16","current":-0.448915,"twenty":-5.486249,"median":-1.627075,"eighty":-0.268073,"marketCap":7652350},{"date":"2026-01-23","current":-0.398582,"twenty":-5.349888,"median":-1.612436,"eighty":-0.268073,"marketCap":6794359},{"date":"2026-01-30","current":-0.334646,"twenty":-5.314836,"median":-1.571587,"eighty":-0.268073,"marketCap":5704479},{"date":"2026-02-06","current":-0.266628,"twenty":-5.191958,"median":-1.541273,"eighty":-0.266911,"marketCap":4545032},{"date":"2026-02-13","current":-0.277511,"twenty":-5.120025,"median":-1.485623,"eighty":-0.266911,"marketCap":4730543},{"date":"2026-02-20","current":-0.253025,"twenty":-5.045098,"median":-1.467001,"eighty":-0.262309,"marketCap":4313142},{"date":"2026-02-27","current":-0.289754,"twenty":-4.990151,"median":-1.389503,"eighty":-0.262248,"marketCap":4939244},{"date":"2026-03-06","current":-0.27207,"twenty":-4.920219,"median":-1.228031,"eighty":-0.262248,"marketCap":4637788},{"date":"2026-03-13","current":-0.266628,"twenty":-4.838928,"median":-1.098666,"eighty":-0.262248,"marketCap":4545032},{"date":"2026-03-20","current":-0.261187,"twenty":-4.709705,"median":-1.034378,"eighty":-0.262248,"marketCap":4452276},{"date":"2026-03-27","current":-0.255745,"twenty":-4.565564,"median":-0.964517,"eighty":-0.259835,"marketCap":4359520},{"date":"2026-04-02","current":-0.22576,"twenty":-4.345285,"median":-0.914361,"eighty":-0.257106,"marketCap":3663852},{"date":"2026-04-10","current":-0.724527,"twenty":-4.223337,"median":-0.886894,"eighty":-0.257106,"marketCap":11758312},{"date":"2026-04-17","current":-0.724527,"twenty":-4.080458,"median":-0.792353,"eighty":-0.257106,"marketCap":11758312},{"date":"2026-04-24","current":-0.578568,"twenty":-4.053264,"median":-0.756527,"eighty":-0.257106,"marketCap":9389545},{"date":"2026-05-01","current":-0.553043,"twenty":-3.979888,"median":-0.7301,"eighty":-0.257106,"marketCap":8975301},{"date":"2026-05-08","current":-0.490648,"twenty":-3.941171,"median":-0.700599,"eighty":-0.257106,"marketCap":7962703},{"date":"2026-05-15","current":-0.536433,"twenty":-3.881672,"median":-0.695716,"eighty":-0.257106,"marketCap":8972506},{"date":"2026-05-22","current":-0.507596,"twenty":-3.841353,"median":-0.656811,"eighty":-0.257106,"marketCap":8490181},{"date":"2026-05-29","current":-0.502983,"twenty":-3.815401,"median":-0.642321,"eighty":-0.257106,"marketCap":8413013},{"date":"2026-06-05","current":-0.43988,"twenty":-3.790474,"median":-0.607488,"eighty":-0.257106,"marketCap":7357549},{"date":"2026-06-12","current":-0.413677,"twenty":-3.762407,"median":-0.578568,"eighty":-0.257106,"marketCap":6919272},{"date":"2026-06-18","current":-0.305954,"twenty":-3.739595,"median":-0.565049,"eighty":-0.257106,"marketCap":5117466},{"date":"2026-06-26","current":-0.298169,"twenty":-3.714156,"median":-0.554442,"eighty":-0.257106,"marketCap":4987253},{"date":"2026-07-02","current":-0.33817,"twenty":-3.69542,"median":-0.537183,"eighty":-0.257106,"marketCap":5656314},{"date":"2026-07-10","current":-0.351588,"twenty":-3.671432,"median":-0.529352,"eighty":-0.257106,"marketCap":5880746},{"date":"2026-07-17","current":-0.230153,"twenty":-3.637837,"median":-0.52246,"eighty":-0.255745,"marketCap":3849592},{"date":"2026-07-24","current":-0.21548,"twenty":-3.637837,"median":-0.50709,"eighty":-0.253025,"marketCap":3604180},{"date":"2026-07-31","current":-0.174341,"twenty":-3.612398,"median":-0.502106,"eighty":-0.251254,"marketCap":2916065},{"date":"2026-08-07","current":-0.127735,"twenty":-3.597091,"median":-0.494205,"eighty":-0.243502,"marketCap":2136523},{"date":"2026-08-14","current":-0.140105,"twenty":-3.561199,"median":-0.491964,"eighty":-0.239421,"marketCap":2343439},{"date":"2026-08-21","current":-0.115206,"twenty":-3.53608,"median":-0.490144,"eighty":-0.235247,"marketCap":1900736},{"date":"2026-08-28","current":-0.179358,"twenty":-3.51064,"median":-0.486932,"eighty":-0.230872,"marketCap":2959149}],"updateTime":1788186513606},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNPX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641512831","title":"Genprex files $250M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2641512831","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641512831?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:05","pubTimestamp":1780693510,"startTime":"0","endTime":"0","summary":"17:03 EDT Genprex (GNPX) files $250M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genprex-files-250m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genprex-files-250m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641735140","title":"Genprex Inc Files for Mixed Shelf of up to $250 Mln – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641735140","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641735140?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:03","pubTimestamp":1780693408,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D0RU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638511794","title":"Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 Asco Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638511794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638511794?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:00","pubTimestamp":1779796817,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA9MTZ0R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635744191","title":"Genprex collaborators present positive preclinical data of GPX-002 in diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2635744191","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635744191?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:54","pubTimestamp":1778777695,"startTime":"0","endTime":"0","summary":"Genprex’s (GNPX) research collaborators presented positive preclinical data on the company’s diabetes gene therapy drug candidate at the 2026 Ameri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genprex-collaborators-present-positive-preclinical-data-of-gpx-002-in-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genprex-collaborators-present-positive-preclinical-data-of-gpx-002-in-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNPX","BK4139","GPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635187755","title":"Genprex Q1 net loss widens 13% to $4.46 million year over year","url":"https://stock-news.laohu8.com/highlight/detail?id=2635187755","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635187755?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:36","pubTimestamp":1778704600,"startTime":"0","endTime":"0","summary":"Genprex posted a net loss of USD 4.46 million for the quarter ended March 31, 2026, widening 13% from the year-earlier period.Research and development expense rose 8% to USD 2.75 million, while general and administrative costs climbed 22% to USD 1.75 million.Other income increased to USD 31,748, while cash and cash equivalents totaled USD 18.05 million as of March 31, 2026.During the quarter, 5,714,798 shares were sold under the 2023 at-the-market facility for net proceeds of about USD 13.36 million.Operationally, Genprex continued enrolling Acclaim-1 and Acclaim-3, targeting interim enrollments in the first half of 2026 with interim analyses expected in the second half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex In","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL4NqTkN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631162634","title":"Genprex Receives Patent Grant From the Israel Patent Office for the Combination of Reqorsa® Gene Therapy and Pd-1 Antibodies to Treat Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2631162634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631162634?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:09","pubTimestamp":1777550972,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41D0R7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631634687","title":"Genprex says Israel grants patent for Reqorsa plus PD-1 antibody cancer treatment combo","url":"https://stock-news.laohu8.com/highlight/detail?id=2631634687","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631634687?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:01","pubTimestamp":1777550470,"startTime":"0","endTime":"0","summary":"Genprex received patent grant from Israel Patent Office covering use of Reqorsa gene therapy with PD-1 antibodies to treat cancer.Grant expands Genprex intellectual property protection for this combination in Israel, adding to patents already issued in major markets.Reqorsa is being developed in combination regimens for lung cancer, with clinical programs in NSCLC and SCLC.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDLpyJy8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630303262","title":"Genprex says diabetes gene therapy reverses hyperglycemia in preclinical Type 2 models","url":"https://stock-news.laohu8.com/highlight/detail?id=2630303262","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630303262?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:04","pubTimestamp":1777374287,"startTime":"0","endTime":"0","summary":"Genprex disclosed that collaborators will present new preclinical results for its GPX-002  diabetes gene therapy at ASGCT 2026 on May 13.Data to be presented show treatment reversed high blood sugar in Type 2 diabetic mouse models within four weeks.Researchers also reported improved insulin-producing cell function and signs of more mature insulin production in treated animals.Genprex highlighted a potential delivery path to humans using an endoscopic procedure to infuse therapy directly into pancreas.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Newswire  on April 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL3tM505:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010463","title":"Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy to Be Released at the 2026 Asco Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010463?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855610,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUA6NYP6M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629911033","title":"Genprex signs MD Anderson research deal to study Reqorsa lung cancer response biomarkers","url":"https://stock-news.laohu8.com/highlight/detail?id=2629911033","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629911033?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:07","pubTimestamp":1776769634,"startTime":"0","endTime":"0","summary":"Genprex on April 21, 2026 signed sponsored research agreement with UT MD Anderson to study biomarkers that could predict response to its Reqorsa gene therapy in lung cancer.Findings have not been presented; work will be used to guide future patient selection for Acclaim-1 and Acclaim-3 clinical trials.Genprex expects biomarker work to help identify patients more likely to benefit from Reqorsa, aiming to improve trial outcomes without changing current trial design disclosures.Update follows earlier Acclaim-1 and Acclaim-3 Phase 1 results already presented internally by Genprex as showing tolerability with early signs of benefit in some patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content u","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL9v0vsW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629038267","title":"Genprex Signs Sponsored Research Agreement to Study Biomarkers That May Predict Patient Response to Reqorsa® Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2629038267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629038267?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:00","pubTimestamp":1776769210,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUAPWCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628374257","title":"Genprex says Reqorsa gene therapy data support potential ALK+ NSCLC clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2628374257","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628374257?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:01","pubTimestamp":1776682895,"startTime":"0","endTime":"0","summary":"Genprex reported positive preclinical results for Reqorsa gene therapy in lung cancer studies presented at 2026 AACR Annual Meeting.Data indicated Reqorsa reduced tumor growth in ALK-positive non-small cell lung cancer models, including settings with resistance to existing ALK inhibitors.Separate findings pointed to TROP2 and PTEN as potential biomarkers to identify patients less likely to respond, supporting a more targeted clinical development strategy.Additional preclinical work showed Reqorsa boosted natural killer cell anti-tumor activity, with tumor suppression observed in animal models.Genprex highlighted these results as support for moving toward a future clinical trial, including a potential program in ALK-positive disease.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL5wQkzM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628742846","title":"Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 Aacr Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628742846","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628742846?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:00","pubTimestamp":1776682803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nTUA3FGMPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628849077","title":"Genprex announces annual shareholder meeting webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2628849077","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628849077?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:36","pubTimestamp":1776458171,"startTime":"0","endTime":"0","summary":"Genprex will hold its 2026 annual stockholders meeting virtually on June 18, 2026.Items up for stockholder vote include election of two Class III directors.Additional proposals cover ratification of WithumSmith+Brown as independent auditor for fiscal 2026.Stockholders will also vote on an amended and restated 2018 Equity Incentive Plan.Other proposals include a charter amendment authorizing a reverse stock split at a ratio ranging from 1-for-5 to 1-for-50, plus authorization to adjourn meeting if needed to solicit additional proxies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL9q8RKh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627255737","title":"Genprex director Brent Longnecker disposes of USD 22 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2627255737","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627255737?lang=en_us&edition=fundamental","pubTime":"2026-04-16 06:51","pubTimestamp":1776293485,"startTime":"0","endTime":"0","summary":"Genprex director Brent Longnecker sold 8 shares of common stock on April 14, 2026 at USD 1.23 per share.Longnecker Associates Ltd, an indirect holder, sold 10 shares at USD 1.23 per share, reducing its position to zero shares.Brent Longnecker reported direct ownership of 9,157 Genprex shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL1xCFGv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","LU0742534661.SGD","LU1804176565.USD","IE00BFXG1179.USD","LU0251131958.USD","AON","LU0251142724.SGD","LU0077335932.USD","BK4532","LU1366333091.USD","BK4173","SGXZ31699556.SGD","SG9999018865.SGD","BK4585","LU1691799644.USD","BK4588","SG9999014880.SGD","SG9999014906.USD","SG9999014898.SGD","LU0048573561.USD","SG9999014914.USD","SG9999017495.SGD","SG9999018857.SGD","LU2265009873.SGD","LU0157215616.USD","BK4559","BK4139","LU1983260115.SGD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623971324","title":"Genprex FY25 net loss narrows 23% to $16M","url":"https://stock-news.laohu8.com/highlight/detail?id=2623971324","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623971324?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:42","pubTimestamp":1774906935,"startTime":"0","endTime":"0","summary":"Genprex posted a net loss of USD 16.2 million in fiscal 2025, narrowing 23%.Research and development expense fell 11% to USD 9.4 million due to Acclaim-2 closure and lower clinical and manufacturing costs.General and administrative expense dropped 43% to USD 6.1 million on lower share-based compensation and cost-cutting.Cash totaled USD 7.8 million at Dec. 31, 2025; net cash used in operating activities improved to USD 15.3 million.Genprex expects to complete interim enrollment for Acclaim-1 and Acclaim-3 in first-half 2026, with interim analyses in second-half 2026, and forecasts cash runway into second-quarter 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL9wXfDp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620237926","title":"Genprex collaborators to present Reqorsa lung cancer preclinical data at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620237926","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620237926?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:02","pubTimestamp":1773831749,"startTime":"0","endTime":"0","summary":"Genprex said its collaborators will present preclinical data on Reqorsa  for lung cancer at the 2026 AACR Annual Meeting on April 19, 2026. One poster reports that low TROP2 and high PTEN expression were identified as potential biomarkers associated with primary resistance to TUSC2 gene therapy in non-small cell lung cancer models. Another poster describes studies in ALK-positive non-small cell lung cancer showing 79% tumor shrinkage with Reqorsa alone or with alectinib in an alectinib-sensitive mouse model, compared with 60% tumor shrinkage with alectinib alone. A third poster reports that restoring TUSC2 function increased natural killer cell cytotoxicity and led to complete tumor regression in 67% of Tusc2 knockout mice and 33% of wild-type mice in a syngeneic tumor model.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL5mBPvy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618173934","title":"Genprex executives to attend BIO Europe Spring 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618173934","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618173934?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:04","pubTimestamp":1773140642,"startTime":"0","endTime":"0","summary":"Genprex executives plan to attend and participate in BIO Europe Spring on March 23-25, 2026 in Lisbon, Portugal. Ryan Confer and Thomas Gallagher are scheduled to be available for one-on-one meetings during the conference. Event-related link: Genprex.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDL9bTKsj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613821377","title":"Genprex granted Japanese and EU patents for Reqorsa Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2613821377","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613821377?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:12","pubTimestamp":1771852367,"startTime":"0","endTime":"0","summary":"Genprex (GNPX) announced that the Japanese Patent Office has issued a favorable Appeal Decision to grant a patent claiming the use of Reqorsa Gene ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genprex-granted-japanese-and-eu-patents-for-reqorsa-gene-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genprex-granted-japanese-and-eu-patents-for-reqorsa-gene-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4156","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613773784","title":"Genprex Wins Japanese and European Patent Grants for Reqorsa Gene Therapy Combinations With PD-1/PD-L1 Immunotherapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2613773784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613773784?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:01","pubTimestamp":1771851680,"startTime":"0","endTime":"0","summary":"Genprex Inc. said the Japanese Patent Office issued a favorable appeal decision to grant a patent covering the use of its Reqorsa gene therapy in combination with PD-L1 antibodies to treat cancer, including use with Tecentriq in its Acclaim-3 study. The company also said the European Patent Office issued a decision to grant a patent covering Reqorsa in combination with PD-1 antibodies to treat cancer.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDLkZgLM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}